Physician profile
Joyce Koh
NPI 1144480484
$4,047.94
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,383 · 2020: $712 · 2021: $1,444 · 2022: $330 · 2023: $164 · 2024: $14.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.00 · Food and Beverage: $79.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.00 |
| Food and Beverage | $79.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $980.59 | 2019-2024 | Xifaxan, Plenvu |
| Abbvie INC. | $819.29 | 2019-2023 | |
| Gilead Sciences, INC. | $573.66 | 2019-2022 | |
| Intercept Pharmaceuticals, INC. | $328.28 | 2019-2022 | |
| Janssen Biotech, INC. | $323.77 | 2019-2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $189.65 | 2019-2023 | Entyvio |
| Celgene Corporation | $184.33 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $127.87 | 2021-2023 | |
| Ironwood Pharmaceuticals, INC | $104.86 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $92.03 | 2019-2020 | |
| Biofire Diagnostics, LLC | $84.96 | 2019 | |
| Romark Laboratories, Lc | $48.21 | 2019-2020 | |
| Redhill Biopharma INC. | $46.85 | 2021 | |
| Braintree Laboratories, INC. | $45.09 | 2019-2020 | |
| Qol Medical, LLC | $22.53 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.83 | 2019 | |
| Alfasigma USA, INC. | $16.50 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.47 | 2019 | |
| Merck Sharp & Dohme LLC | $13.49 | 2022 | |
| Daiichi Sankyo INC. | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Koh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.